analysis of statistics

Diplomat Pharmacy Inc (NYSE:DPLO)’s share price soared 8.53% or 0.5 to reach at $6.36 during previous trading session. A total of 1.87 Million shares exchanged hands, whereas the company’s average trading volume stands at 1.38 Million shares. Diplomat Pharmacy Inc (NYSE:DPLO) has a market capitalization of $547.85 Million and most recently 86.14 Million outstanding shares have been calculated.

According to sentiments of 8 analysts the mean estimates of short term price target for the company’s stock is marked at $6.94. The most optimistic analyst sees the stock reaching $10 while the most conventional predicts the target price at $5.

In terms of Buy/Sell recommendations, 11 analysts have a consensus rating of 2.91 on the shares of Diplomat Pharmacy Inc (NYSE:DPLO). Out of rating recommendations 0 have given the stock a Buy while 1 recommend the stock as Outperform. 9 have given the stock a Hold rating, 1 as Underperform and 0 as Sell.

Diplomat Pharmacy Inc (NYSE:DPLO)’s shares slipped -0.93% in the past week and plunged -55.52% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -67.23% while its year to date performance is at -52.75%.

While taking a glance at financials, we can look at a number of key indicators. Diplomat Pharmacy Inc (NYSE:DPLO) has a Return on Assets (ROA) of 0.2. The company currently has a Return on Equity (ROE) of 0.4 and a Return on Investment (ROI) of 1.2. Average true range (ATR-14) of the company sets at 0.66, along with its weekly and monthly volatility of 10.34% and 10.21% respectively. Relative strength index (RSI-14) for Diplomat Pharmacy Inc (NYSE:DPLO) is at 36.11. Beta value of the stock stands at 0.75.

The company’s price to free cash flow for trailing twelve months is 4.39. Its quick ratio for most recent quarter is 0.7 along with current ratio for most recent quarter of 1. Total debt to equity ratio of Diplomat Pharmacy Inc (NYSE:DPLO) for most recent quarter is 0.82 whereas long term debt to equity ratio for most recent quarter is 0.58.

Shares of Matador Resources Company (NYSE:MTDR) soared 1.78% or 0.35 to reach at $20 during previous trading session. Matador Resources Company (NYSE:MTDR) has a market capitalization of $2.31 Billion and most recently 115.39 Million outstanding shares have been calculated. A total of 2.82 Million shares exchanged hands, whereas the company’s average trading volume stands at 2.35 Million shares.

According to 20 analysts Matador Resources Company (NYSE:MTDR)’s price will reach at $26.35 during 52 weeks. Stock’s minimum price target estimates has been figured out at $20 while the maximum price target forecast is established at $33.

According to the recommendations from 17 analysts stock has mean rating of 2.06 on the shares of Matador Resources Company (NYSE:MTDR). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 8 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of Matador Resources Company (NYSE:MTDR) climbed 7.93% in the past week and soared 5.6% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -36.99% while its year to date performance is at 28.78%.

Total debt to equity ratio of Matador Resources Company (NYSE:MTDR) for most recent quarter is 0.77 whereas long term debt to equity ratio for most recent quarter is 0.77. The company’s price to free cash flow for trailing twelve months is 5.21. Its quick ratio for most recent quarter is 0.9 along with current ratio for most recent quarter of 0.9.

Average true range (ATR-14) of the company sets at 0.81, along with its weekly and monthly volatility of 3.90% and 4.52% respectively. Relative strength index (RSI-14) for Matador Resources Company (NYSE:MTDR) is at 62.72. Beta value of the stock stands at 1.89. Matador Resources Company (NYSE:MTDR) has a Return on Assets (ROA) of 9.6. The company currently has a Return on Equity (ROE) of 18.3 and a Return on Investment (ROI) of 11.4.